Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes

被引:127
作者
Tanaka, Y
Marusawa, H
Seno, H
Matsumoto, Y
Ueda, Y
Kodama, Y
Endo, Y
Yamauchi, J
Matsumoto, T
Takaori-Kondo, A
Ikai, I
Chiba, T [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Surg Gastroenterol, Kyoto 6068507, Japan
基金
日本学术振兴会;
关键词
APOBEC3G; interferon-alpha; hepatocytes;
D O I
10.1016/j.bbrc.2005.12.192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein B mRNA-editing enzyme catalytic-polypeptide 3G (APOBEC3G) is a potent inhibitor of infection by a wide range of retroviruses. Although recent reports have suggested that human APOBEC3G exerts antiviral activity against hepatitis B virus, APOBEC3G expression is normally low in the human liver. To clarify the role of APOBEOG in cellular defenses against hepatitis Viruses, the regulation of the APOBEOG expression was investigated in human hepatocytes. Endogenous transcripts of nine APOBEC family members were barely detectable in quiescent liver cells. However, APOBEC3G was significantly up-regulated in response to interferon-alpha (IFN-alpha) stimulation in HepG2 Huh-7, and primary human hepatocytcs. IFN regulatory factor elements that are important for IFN-inducible promoter activity were identified 5' upstream from the human APOBEC3G gene. Our findings provided the first evidence showing that APOBEOG is induced by IFN stimulation in human hepatocytes and thus could be involved in host defense mechanisms directed against hepatitis Viruses. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 30 条
[1]   Intrinsic immunity: a front-line defense against viral attack [J].
Bieniasz, PD .
NATURE IMMUNOLOGY, 2004, 5 (11) :1109-1115
[2]   Cytidine deamination of retroviral DNA by diverse APOBEC proteins [J].
Bishop, KN ;
Holmes, RK ;
Sheehy, AM ;
Davidson, NO ;
Cho, SJ ;
Malim, MH .
CURRENT BIOLOGY, 2004, 14 (15) :1392-1396
[3]   Current therapy for chronic hepatitis C [J].
Davis, GL .
GASTROENTEROLOGY, 2000, 118 (02) :S104-S114
[4]   TUMOR-NECROSIS-FACTOR-ALPHA NEGATIVELY REGULATES HEPATITIS-B VIRUS GENE-EXPRESSION IN TRANSGENIC MICE [J].
GILLES, PN ;
FEY, G ;
CHISARI, FV .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3955-3960
[5]   Death by deamination: A novel host restriction system for HIV-1 [J].
Goff, SP .
CELL, 2003, 114 (03) :281-283
[6]   DNA determination mediates innate immunity to retroviral infection [J].
Harris, RS ;
Bishop, KN ;
Sheehy, AM ;
Craig, HM ;
Petersen-Mahrt, SK ;
Watt, IN ;
Neuberger, MS ;
Malim, MH .
CELL, 2003, 113 (06) :803-809
[7]   Retroviral restriction by APOBEC proteins [J].
Harris, RS ;
Liddament, MT .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (11) :868-877
[8]   INTERFERON INHIBITS HEPATITIS-B VIRUS-REPLICATION IN A STABLE EXPRESSION SYSTEM OF TRANSFECTED VIRAL-DNA [J].
HAYASHI, Y ;
KOIKE, K .
JOURNAL OF VIROLOGY, 1989, 63 (07) :2936-2940
[9]   A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes [J].
Hino, H ;
Tateno, C ;
Sato, H ;
Yamasaki, C ;
Katayama, S ;
Kohashi, T ;
Aratani, A ;
Asahara, T ;
Dohi, K ;
Yoshizato, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (01) :184-191
[10]   Siah-1L, a novel transcript variant belonging to the human Siah family of proteins, regulates β-catenin activity in a p53-dependent manner [J].
Iwai, A ;
Marusawa, H ;
Matsuzawa, S ;
Fukushima, T ;
Hijikata, M ;
Reed, JC ;
Shimotohno, K ;
Chiba, T .
ONCOGENE, 2004, 23 (45) :7593-7600